Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normast MPS in Fibromyalgia Patients
NCT04488926Phase 4Completed
- Sponsor
- Epitech Group
- Start
- Jul 2020
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial, sponsored by Epitech Group. Primary endpoint: Fibromyalgia Impact Questionnaire Revised at 90 days. Started Jul 2020; status: completed.
Beyond the preview
Go deeper on NCT04488926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04488926.